Deborah Berg

6.2k citations
66 papers · 3.6k · 2 hit papers · h-index 24

Impact in

  • Hematology top 0.2%
    • Acute Myeloid Leukemia Research
    • Multiple Myeloma Research and Treatments
    • Hematopoietic Stem Cell Transplantation
  • Genetics top 2%

Papers in

    • Protein Degradation and Inhibitors 28
    • Ubiquitin and proteasome pathways 17
    • Amyloidosis: Diagnosis, Treatment, Outcomes 9
    • Multiple Myeloma Research and Treatments 42
    • Acute Myeloid Leukemia Research 7

Deborah Berg

64 papers receiving 3.5k citations

Hit Papers

Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype. 1998 · 508 citations
5080+10+21Years since publication2505007501000

Peers

Deborah Berg
Comparison fields: 5 of 97
  • Hematology 2.9k
  • Genetics 584
  • Oncology 1.1k
  • Molecular Biology 2.0k
  • Public Health, Environmental and Occupational Health 819
Replace Claude Gardin with:
Claude Gardin France
Åsa Rangert Derolf Sweden
Ellin Berman United States
Bart L. Scott United States
Agnieszka Wierzbowska Poland
Ralph Wäsch Germany
Virginia M. Klimek United States
Mar Tormo Spain
H. Jean Khoury United States
Laura Rosiñol Spain
Deborah Berg relative to Claude Gardin France Claude Gardin's profile →
Citations per field
00.5×1.5×
Claude Gardin · 1×
Citations per year

Countries citing papers authored by Deborah Berg

Since Specialization
Citations

This map shows the geographic impact of Deborah Berg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah Berg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah Berg more than expected).

Fields of papers citing papers by Deborah Berg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah Berg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah Berg. The network helps show where Deborah Berg may publish in the future.

Co-authors

The 25 scholars most cited alongside Deborah Berg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Deborah Berg Line = papers co-authored together Deborah Berg links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Intensive Postremission Chemotherapy in Adults with Acute Myeloid Leukemia
Hit paper breakdown →
19941027
2
Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.
Hit paper breakdown →
1998508
3 1995335
4 2014205
5 2014166
6 2014157
7 2001150
8 2017101
9 195364
10 199262
11
Intensive postremission therapy in adults with acute nonlymphocytic leukemia using various dose schedules of ara-C: a progress report from the CALGB. Cancer and Leukemia Group B.
198754
12 201740
13 201739
14 201739
15 201938
16 201836
17 201535
18 202135
19 201932
20 201129

About Deborah Berg

Deborah Berg is a scholar working on Molecular Biology, Hematology, Oncology, Genetics and Pathology and Forensic Medicine, having authored 66 papers that have together received 3.6k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (42 papers), Protein Degradation and Inhibitors (28 papers), Chronic Lymphocytic Leukemia Research (18 papers), Ubiquitin and proteasome pathways (17 papers), Peptidase Inhibition and Analysis (13 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (9 papers), Cancer Treatment and Pharmacology (8 papers) and Acute Myeloid Leukemia Research (7 papers). The work is most often cited by research in Hematology (2.9k citations), Genetics (584 citations), Oncology (1.1k citations), Molecular Biology (2.0k citations) and Public Health, Environmental and Occupational Health (819 citations). Deborah Berg has collaborated with scholars based in United States, Canada and Italy. Frequent co-authors include Charles A. Schiffer, Robert J. Mayer, Philip Schulman, Joseph O. Moore, Bayard L. Powell, George Omura, E Frei, O. Ross McIntyre, Roger B. Davis and Neeraj Gupta. Their work appears in journals such as Blood, Journal of Clinical Oncology, Leukemia, Cancer and British Journal of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact